Missouri HB2127 mandates p53 testing for all abnormal endometrial samples to diagnose uterine cancer.
Missouri HB2127 introduces "Cindi's Law," which requires a p53 test on all abnormal endometrial samples for uterine cancer diagnosis. This test, which detects abnormalities in the p53 protein, must be performed in addition to any other tests. The law aims to enhance diagnostic accuracy and treatment planning for uterine cancer.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.